[Primary ulcero-necrotizing enterocolitis of the newborn. Advancements in management. Improvement in prognosis].

We report our experience acquired over the last seven years with the management of necrotizing enterocolitis in neonates. This condition occurs mainly in small-for-dates, premature, critically ill infants. Diagnosis rests on the combination of clinical evidence of intestinal obstruction with non-specific signs of a decline in general health and suggestive roentgenographic findings.

[Multifocal Candida albicans osteoarthritis in an infant].

The authors report a case of candidal arthritis and osteomyelitis in a five-month-old child. Parenteral nutrition with central catheter, broad-spectrum antibiotherapy, repeated gastrointestinal surgery are the main risk factors. The prognosis for this bone and joint infection is favourable.

Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child.

We report the efficacy of a long-acting somatostatin analogue, associated with conventional therapy, in controlling profuse ileostomy losses in a child with short bowel syndrome following a volvulus. The first therapeutic effects of the treatment [50 to 100 micrograms/day of SMS 201-995 (Sandoz Ltd.) subcutaneously] appeared 48 h after institution.